Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 29, 2000

View Archived Issues

Innovata and Vectura to develop inhaled protein and peptide drugs

FDA approves Visicol

Targeted Genetics completes acquisition of Genovo; initiates project with Biogen

New prostate cancer vaccine selected for clinical trials by Progenics, Cytogen

Variagenics and Boehringer Ingelheim join forces for pharmacogenomics program

Autoantibodies found to be associated with autoimmune autonomic neuropathy

Italian researchers report new classes of highly potent nootropic agents

Potential antiatherosclerotic agents presented in Bologna by Latvian investigators

Results of marimastat/carboplatin combination trial in ovarian cancer disappointing

New inhibitors of IMP-1 metallo-beta-lactamase tested in combination with imipenem

Two-antigen combination melanoma vaccine enters phase I/II at MGH

Theratechnologies enhances therapeutic peptide pipeline through acquisition

BioTransplant and Novartis create xenotransplantation research company

Corixa to file Melacine BLA for stage II melanoma

Cytokine grants CNI-1493 license to Axxima

Novasite awarded Phase I SBIR grant for lead molecule identification

O-Vax ovarian cancer vaccine awarded orphan drug status in U.S.

Ampligen clears first stage of regulatory review in the E.U.

AstraZeneca synthesizes new selective opioid agonist analgesics

Fujisawa discontinues development of FK-888

Sagami receives patent for apoptosis inhibitor

3-D researchers patent alphav integrin inhibitors with broad indications

Novel vitronectin receptor antagonists and their use in bone disorders patented

Sanofi-Synthelabo presents new selective NK1 receptor antagonists

University of Virginia researchers patent felbamate derivatives useful for neurological diseases

Neurological compounds disclosed by Cephalon in patent literature

New MMP inhibitors useful for multiple sclerosis, etc.

Eisai receives patent for new compounds interacting with AMPA receptors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...